Abstract
Wilkins and colleagues evaluate the utility of the World Health Organization (WHO) diagnostic criteria intended to separate cases previously classified as essential thrombocythemia (ET) into 2 groups: "true ET" and "prefibrotic myelofibrosis." Focusing on bone marrow histology, the authors found substantial variation in classification of cases.
Original language | English (US) |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | Blood |
Volume | 111 |
Issue number | 1 |
DOIs |
|
State | Published - Jan 1 2008 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology